| Dr Mark D Callaway, DDS | |
|
6401 Tower Ave, Superior, WI 54880-6061 | |
| (715) 392-1529 | |
| Not Available |
| Full Name | Dr Mark D Callaway |
|---|---|
| Gender | Male |
| Speciality | Dentist - General Practice |
| Location | 6401 Tower Ave, Superior, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144248287 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 4626 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark D Callaway, DDS 6401 Tower Ave, Superior, WI 54880-6061 Ph: (715) 392-1529 | Dr Mark D Callaway, DDS 6401 Tower Ave, Superior, WI 54880-6061 Ph: (715) 392-1529 |
News Archive
Injections of botulinum toxin A (botox) into the prostate are a promising alternative treatment for the millions of men who have benign prostatic hyperplasia (BPH), a condition commonly referred to as enlarged prostate, according to a study conducted by the University of Pittsburgh School of Medicine and Chang Gung Memorial Hospital in Taiwan.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the presentation of new pre-clinical data from its hypercholesterolemia program, performed in collaboration with scientists at the University of Texas Southwestern Medical Center at Dallas. The data were presented at the PCSK9 Conference: From Gene to Therapeutics held in Nantes, France from March 11-13, 2010.
Myriad Genetics has announced the issuance of Patent No. 6,911,466 entitled, "AB42 Lowering Agents". Myriad holds exclusive rights to the patent under a licensing agreement with Mayo Clinic. The patent covers methods of using a broad class of compounds known as selective amyloid beta 42 lowering agents (SALAs) to lower levels of the toxic peptide.
The use of general anesthesia is a routine part of surgical operations at hospitals and medical facilities around the world, but the precise biological mechanisms that underlie anesthetic drugs' effects on the brain and the body are only beginning to be understood. A review article in the December 30 New England Journal of Medicine brings together for the first time information from a range of disciplines, including neuroscience and sleep medicine, to lay the groundwork for more comprehensive investigations of processes underlying general anesthesia.
› Verified 2 days ago
Dr. Jon Gregorie Nelson, D.D.S Dentist Medicare: Medicare Enrolled Practice Location: 418 23rd Ave E, Superior, WI 54880 Phone: 715-398-3239 Fax: 715-398-5799 | |
Dr. Kirkland A Fehrman, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 2222 E 5th St, Superior, WI 54880 Phone: 715-394-5411 Fax: 715-392-5086 | |
Thomas A Linstroth, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 3600 Tower Ave, Superior, WI 54880 Phone: 715-394-5411 | |
Dr. Arthur David Zehm, DDS Dentist Medicare: Medicare Enrolled Practice Location: 1507 Tower Ave, Ste 409, Superior, WI 54880 Phone: 715-392-3499 | |
Dr. Kevin M Mikel, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 3312 Tower Avenue, Superior, WI 54880 Phone: 715-392-1132 Fax: 715-392-2333 | |
Dr. John E Conkright, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 823 Belknap St, Suite 220, Superior, WI 54880 Phone: 715-392-4545 Fax: 715-392-4547 |